Marc Van DijkChief Scientific Officer of Antibody Discovery and Engineering at FairJourney BiologicsSpeaker
Profile
Marc heads up Discovery and Engineering at Fairjourney Bio, with teams in Porto and Cambridge UK. He previously was VP Antibody Technology at Genmab, chief technology officer at 4-Antibody and Agenus, and Chief Scientific Officer at MiNK therapeutics. He has been active in the antibody field for 30 years.
Agenda Sessions
Engineering Switch antibodies – the case of IL-12
, 12:05pmView Session
